Opinion
Eline van Beest
Eline founded the TUDelft spin-off and MedTech scale-up NightBalance in 2009 with a new therapy for sleep apnea. NightBalance was acquired by Philips in 2018. She went on to spin out Hybridize Therapeutics from the LUMC, developing an RNA therapeutic for BK Virus, now outlicensed to AiCuris and currently progressing towards Phase II clinical trial. Currently, she Operating Partner at Thuja Capital and Professor of Practice at the Delft University of Technology. Besides that, she is part of the Investment Committee of the Deep Tech Fund of EZ & InvestNL, the VGZ Voorop in Zorg Fonds and the Graduate Ventures Pre Seed Fund and is a member of the Supervisory Board of Yes!Delft (a leading tech incubator in Europe supporting 280 startups).
Eline founded the TUDelft spin-off and MedTech scale-up NightBalance in 2009 with a new therapy for sleep apnea. NightBalance was acquired by Philips in 2018. She went on to spin out Hybridize Therapeutics from the LUMC, developing an RNA therapeutic for BK Virus, now outlicensed to AiCuris and currently progressing towards Phase II clinical trial. Currently, she Operating Partner at Thuja Capital and Professor of Practice at the Delft University of Technology. Besides that, she is part of the Investment Committee of the Deep Tech Fund of EZ & InvestNL, the VGZ Voorop in Zorg Fonds and the Graduate Ventures Pre Seed Fund and is a member of the Supervisory Board of Yes!Delft (a leading tech incubator in Europe supporting 280 startups).
Eline founded the TUDelft spin-off and MedTech scale-up NightBalance in 2009 with a new therapy for sleep apnea. NightBalance was acquired by Philips in 2018. She went on to spin out Hybridize Therapeutics from the LUMC, developing an RNA therapeutic for BK Virus, now outlicensed to AiCuris and currently progressing towards Phase II clinical trial. Currently, she Operating Partner at Thuja Capital and Professor of Practice at the Delft University of Technology. Besides that, she is part of the Investment Committee of the Deep Tech Fund of EZ & InvestNL, the VGZ Voorop in Zorg Fonds and the Graduate Ventures Pre Seed Fund and is a member of the Supervisory Board of Yes!Delft (a leading tech incubator in Europe supporting 280 startups).